Cellectis

Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.

Cellectis S.A. - American Depositary Shares

Cellectis SA

News

Press Releases

Cellectis Presents 'Smart CAR T' Strategy to Enhance Efficacy Against Solid Tumors at AACR-IO 2025

Cellectis to Report Fourth Quarter and Full Year 2024 Financial Results on March 13, 2025

Earnings

Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2024 and Provides a Business Update

Cellectis Presents Non-Viral Gene Editing and Base Editing Innovation at the ASGCT Annual Meeting

Cellectis to Report First Quarter Financial Results on May 12, 2025

Cellectis Reports Financial Results for the First Quarter 2025

Cellectis' Annual Shareholders General Meeting to be Held on June 26, 2025

Management

Cellectis Reports Results from Shareholders Meeting Held on June 26, 2025

Cellectis to Report Second Quarter 2025 Financial Results on August 4, 2025

Short Sellers

Cellectis Reports Second Quarter 2025 Financial Results & Business Updates

CLLS

Abeona Therapeutics

Aldeyra Therapeutics, Inc. - Common Stock

Aldeyra Therapeutics

Alector

Altimmune

Amarin Corporation plc - American Depositary Shares

Amarin Corp

Candel Therapeutics

Capricor Therapeutics, Inc. - Common Stock

Capricor Therapeutics

Bright Minds Biosciences Inc. - common stock

Bright Minds Biosciences

enGene Holdings

4D Molecular Therapeutics, Inc. - Common Stock

4D Molecular Therapeutics

Foghorn Therapeutics

Galectin Therapeutics Inc. - Common Stock

Galectin Therapeutics

Monte Rosa Therapeutics, Inc. - Common Stock

Monte Rosa Therapeutics

I-MAB

Immuneering Corporation - Class A Common Stock

Immuneering

Invivyd

Korro Bio

Lineage Cell Therapeutics, Inc. Common Stock

Lineage Cell Therapeutics

Lexeo Therapeutics

Monopar Therapeutics

Mereo BioPharma Group plc - American Depositary Shares

Mereo BioPharma Group

Neurogene

Ocugen

ProKidney Corp. - Class A Ordinary Shares

ProKidney

Tectonic Therapeutic, Inc. - Common Stock

Comments

Cellectis

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL